Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: IR responded to my question asking if licensing can continue during the dispute

Frankly, I don't think they know for sure if it will either (didn't they say as much in their PR?).

I guess whether licensing will continue or not is a grey area. At least we know the dispute doesn't require that licensing be halted while they're duking it out FWIW. The Market will have to decide for now what the future will hold in that regard IMHO.

GLTAL

Share
New Message
Please login to post a reply